Subcutaneous Immunoglobulin (SCIG) Market Forecast: How Big Will It Be by 2030?
Uncover key drivers, emerging technologies, and competitive movements shaping the subcutaneous immunoglobulin (scig) market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Subcutaneous Immunoglobulin (SCIG) Market reach by 2030 starting from 2026 levels?
The subcutaneous immunoglobulin (scig) market size has experienced rapid expansion in recent years. It is projected to grow from $14.39 billion in 2025 to $16.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.4%. The historical market growth can be attributed to factors such as an increase in the diagnosis of primary immunodeficiency disorders, the inherent limitations of intravenous immunoglobulin therapy, a rising demand for long-term immune support, the improved safety profile of scig, and a growing patient preference for at-home care.
The market for subcutaneous immunoglobulin (scig) is projected to experience substantial growth in the upcoming years. It is forecast to reach $25.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is primarily driven by several factors, including the broadened applications of scig beyond immunodeficiency, a greater emphasis on homecare treatments within healthcare, innovations in infusion technologies, the increasing occurrence of autoimmune and neurological conditions, and a heightened need for patient-centered care approaches. Key trends anticipated during this period encompass a notable transition from intravenous immunoglobulin (ivig) to scig treatments, an increase in the adoption of home-based immunoglobulin therapy, a stronger inclination towards self-administration equipment, the expanded application of scig in managing chronic immune conditions, and a greater necessity for sustained immune replacement therapy.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp
Which Drivers Are Influencing Long-Term Growth In The Subcutaneous Immunoglobulin (SCIG) Market?
The growing occurrence of secondary immunodeficiency diseases is anticipated to stimulate the expansion of the subcutaneous immunoglobulin market in the future. These conditions involve a diminished or weakened immune system, resulting from causes unrelated to the immune system itself. Several factors contribute to the widespread nature of secondary immunodeficiency diseases, including an aging population, the application of immunosuppressive therapies, and exposure to environmental toxins. Subcutaneous immunoglobulin treatment delivers antibodies to fortify the compromised immune system, particularly for chronic conditions such as HIV or autoimmune diseases, thereby guarding against infections and maintaining immunological function during treatment. For instance, in October 2024, the UK-based treatment activist organization HIV i-Base reported that in 2023, new HIV diagnoses rose by 36% among heterosexual men, from 445 in 2022 to 605, and by 30% among heterosexual women, from 602 in 2022 to 780. Consequently, the rising incidence of secondary immunodeficiency diseases is a key driver for the growth of the subcutaneous immunoglobulin market.
How Is The Subcutaneous Immunoglobulin (SCIG) Market Divided Into Segments?
The subcutaneous immunoglobulin (scig) market covered in this report is segmented –
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
What Trends Are Reshaping The Dynamics Of The Subcutaneous Immunoglobulin (SCIG) Market?
Leading companies in the subcutaneous immunoglobulin (SCIG) market are prioritizing the development of advanced solutions, such as prefilled, ready-to-use formulations, to enhance the convenience of treatment, support self-administration, and improve the overall patient experience. Ready-to-use SCIG formulations are premeasured, stable immunoglobulin products designed for subcutaneous delivery, enabling patients with primary immunodeficiency and other immune disorders to administer their therapy more easily outside of clinical settings. For example, in April 2023, the U.S. Food and Drug Administration (FDA) approved a 50 mL / 10 g prefilled syringe presentation of Hizentra (Immune Globulin Subcutaneous [Human] 20%), offering patients a simplified, ready-to-use option that supports more convenient home infusion and enhances treatment adherence.
Which Major Firms Are Strengthening Their Position In The Subcutaneous Immunoglobulin (SCIG) Market?
Major companies operating in the subcutaneous immunoglobulin (scig) market are CSL Behring, Grifols S.A., Octapharma AG, Kedrion Biopharma, LFB Group, Biotest AG, Bio Products Laboratory Ltd., ADMA Biologics Inc., Kamada Pharmaceuticals, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bharat Serums and Vaccines Limited, Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson, Lonza Group, Argenx SE, CinnaGen Co., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Shows The Strongest Potential For Future Expansion In The Subcutaneous Immunoglobulin (SCIG) Market?
North America was the largest region in the subcutaneous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (scig) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Subcutaneous Immunoglobulin (SCIG) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15935&type=smp
Browse Through More Reports Similar to the Global Subcutaneous Immunoglobulin (SCIG) Market 2026, By The Business Research Company
Subcutaneous Immunoglobulin Scig Market Report 2026
Immunoglobulins Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Intravenous Immunoglobulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
